With regards to GFAP as a prognostic biomarker poststroke, Xiong et al. [32], in an attempt to investigate the utility of GFAP testing in distinguishing between intracerebral hemorrhage (ICH) and ischemic stroke (IS), studied both ICH and IS patients and evaluated their GFAP levels early after stroke onset. This evidence concerns the gene GFAP and intracerebral hemorrhage.